There may be cases when business pressures affect personal care. Second important disclaimer: It can be very fashionable to say these companies are more interested in their quarterly profits than the best interest of the patient. Whether you decide to fight ‘em or join ‘em, however, we just can’t pretend these major new players don’t exist. There’s no right or wrong answer in a vacuum. You have to make the decision that’s right for you, your family, and your practice. This might be a long conversation, or several, with your business partner, spouse, clergyman, or bartender. If you’ve been struggling with this decision, I suggest reading part 2 of our series on vision and strategy, to see where you stand. They have their own vision for their culture and operations. Other practice principals feel they would lose control over the way they treat patients. The stress of operations is shared with someone else, so providers can focus on practicing medicine. For some practice owners, a relationship with one of these firms is the answer to a lot of headaches. It could be an excellent decision for your practice to sell equity to one of these firms or engage in a different level of strategic partnership with them. Some might be very happy with their corporate partners and some might not be. I have good friends that work for these companies or have affiliated their practices with them. compete with or join them. just don't pretend they don't exist My observations and opinions are exactly those, based on information that has been publicly released by these companies or covered in the press. Rather, it is a curated synopsis of public information. This profile is not a revelation of insider knowledge. We work or have worked with clinics in some of their networks. Our partnership with Gulf Capital, which has a storied and long history of value addition and operational expertise, will help accelerate our growth internationally and position us as one of the largest global IVF fertility platforms.Important disclaimer: Neither I, nor Fertility Bridge have a direct commercial relationship with these companies at time of writing, though we certainly may in the future. We shall continue to deliver the best treatments and services to our patients so that they receive the best value for their money. We have world-renowned IVF specialists and embryologists working in state-of-the-art facilities. The cornerstone of our success is good science and technology, which translates into the best medical outcomes for our patients. Suresh Soni, CEO of IVI-RMA Middle East, said: "We are excited to partner with Gulf Capital as we embark on our next phase of expansion and growth. The investment in IVI-RMA Middle East is Gulf Capital's largest equity investment to date and is the first corporate carve-out in our Firm's history." IVI-RMA Middle East is the fastest growing IVF service provider in the GCC, and we are excited to be collaborating with its strong management team to take this platform to the next level. This transaction exemplifies Gulf Capital's tried and tested strategy of acquiring controlling stakes in market leading companies in high growth sectors. The company and Gulf Capital will also be opportunistically looking at acquisitions in other geographies.ĭr Karim El Solh, CEO of Gulf Capital, said: "We are thrilled to back the strongest management and medical team within the IVF sector regionally. The plan will see the launch of a new platform-wide brand identity in 2020, the inauguration of a state-of-the-art genetics lab in Abu Dhabi, and expanding the number of clinics by more than three-fold to nine clinics taking the provider to new markets in the Middle East, Asia and Europe. The new chapter of IVI-RMA Middle East will see the implementation of an ambitious three-year plan. With increased awareness coupled with the technological advancements in the field, the fertility sector in the GCC is forecasted to continue to grow at more than 15 per cent CAGR annually over the next five years. Gulf Capital is actively targeting investments within the fast growing and defensive healthcare sector and has identified the fertility sub-sector as a key focus priority, given its expected double-digit growth rates across the region. The transaction is a corporate carve-out of the Middle Eastern clinics of IVI-RMA, the largest IVF service provider globally, and continues Gulf Capital's strategy of acquiring controlling stakes in market leaders. Gulf Capital has announced its three-year growth plans for IVI-RMA Middle East, the fastest growing provider of fertility treatment services in the GCC, following its acquisition of 100 per cent of its stake for over $100 million.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |